Who is sponsoring IDPNHD?

IDPNHD is sponsored by Fresenius Kabi.

What condition does IDPNHD study?

IDPNHD studies Malnutrition, Complication of Hemodialysis.

What drugs are being tested in IDPNHD?

Interventions: Intradialytic Parenteral Nutrition (IDPN).

Last reviewed 2016-03-01 · How we verify

Randomized Study on the Effect of Intradialytic Parenteral Nutrition in Malnourished Hemodialysis Patients (IDPNHD)

NCT00501956 Phase 4 COMPLETED

Malnutrition is a major cause of death in chronic hemodialysis patients. Primary treatment of malnutrition in these patients is dietetic counseling, additional enteral nutrition and occasionally drug therapy. In cases where primary treatment of malnutrition is not effective, intradialytic parenteral nutrition (IDPN)during dialysis therapy may be administered. Using IDPN aminoacids, carbohydrates and fatty acids as well as vitamins and trace elements can be given to the patients. Effectiveness of IDPN has to be verified.

Details

Lead sponsor	Fresenius Kabi
Phase	Phase 4
Status	COMPLETED
Enrolment	140
Start date	2004-07
Completion	2010-12

Conditions

Malnutrition
Complication of Hemodialysis

Interventions

Intradialytic Parenteral Nutrition (IDPN)

Primary outcomes

Change in prealbumin levels — 8 weeks

Countries

Germany